Human T-Lymphotropic Virus Type I (HTLV-1) Infection among Iranian Blood Donors: First Case-Control Study on the Risk Factors

被引:14
|
作者
Hedayati-Moghaddam, Mohammad Reza [1 ]
Tehranian, Farahnaz [2 ,3 ]
Bayati, Maryam [2 ,3 ]
机构
[1] Iranian Acad Ctr Educ Culture & Res ACECR, Res Ctr HIV AIDS HTLV & Viral Hepatitis, Mashhad Branch, Mashhad 917751376, Iran
[2] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran 146651157, Iran
[3] Razavi Khorasan Blood Transfus Ctr, Mashhad 9137913119, Iran
来源
VIRUSES-BASEL | 2015年 / 7卷 / 11期
关键词
HTLV-1; infection; risk factors; blood donors; Mashhad; Iran; EPIDEMIOLOGY; POPULATION; SEROPREVALENCE; SEROPOSITIVITY; RETROVIRUS; NORTHEAST; MASHHAD;
D O I
10.3390/v7112904
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human T-cell lymphotropic virus type 1 (HTLV-1) infection is an endemic condition in Northeast Iran and, as such, identification of risk factors associated with the infection in this region seems to be a necessity. All the possible risk factors for HTLV-1 seropositivity among first-time blood donors were evaluated in Mashhad, Iran, during the period of 2011-2012. Blood donation volunteers were interviewed for demographic data, medical history, and behavioral characteristics and the frequencies of risk factors were compared between HTLV-1 positive (case) and HTLV-1 negative (control) donors. The data was analyzed using Chi square and t-tests. Logistic regression analysis was performed to identify independent risk factors for the infection. Assessments were carried out on 246 cases aged 17-60 and 776 controls aged 17-59, who were matched based on their ages, gender, and date and center of donation. Logistic analysis showed low income (OR = 1.53, p = 0.035), low educational level (OR = 1.64, p = 0.049), being born in the cities of either Mashhad (OR = 2.47, p = 0.001) or Neyshabour (OR = 4.30, p < 0001), and a history of blood transfusion (OR = 3.17, p = 0.007) or non-IV drug abuse (OR = 3.77, p < 0.0001) were significant predictors for infection with HTLV-1. Lack of variability or small sample size could be reasons of failure to detect some well-known risk factors for HTLV-1 infection, such as prolonged breastfeeding and sexual promiscuity. Pre-donation screening of possible risk factors for transfusion-transmissible infections should also be considered as an important issue, however, a revision of the screening criteria such as a history of transfusion for more than one year prior to donation is strongly recommended.
引用
收藏
页码:5736 / 5745
页数:10
相关论文
共 50 条
  • [1] A case-control study of risk factors for seropositivity to human T-Lymphotropic virus type I (HTLV-I) in Jamaica
    Murphy, EL
    Wilks, R
    Hanchard, B
    Cranston, B
    Figueroa, JP
    Gibbs, WN
    Murphy, JYN
    Blattner, WA
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1996, 25 (05) : 1083 - 1089
  • [2] Human T-lymphotropic virus type 1 (HTLV-1)
    Lefrère, JJ
    [J]. PRESSE MEDICALE, 2000, 29 (20): : 1134 - 1138
  • [3] A CASE-CONTROL STUDY OF RISK-FACTORS FOR INFECTION WITH HUMAN T-LYMPHOTROPIC VIRUSES TYPE-I AND TYPE-II (HTLV-I AND HTLV-II) AMONG US BLOOD-DONORS
    MURPHY, EL
    SCHREIBER, G
    CHIEN, HC
    NASS, C
    GARFEIN, RS
    OWNBY, H
    SMITH, JW
    FRIDEY, J
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1995, 141 (11) : S44 - S44
  • [4] Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients
    Santos, Rilma F. S.
    Conceicao, Gildasio C.
    Martins, Marcia S.
    Kraychete, Angiolina
    Penalva, Maria A. C.
    Carvalho, Edgar M.
    Lopes, Antonio Alberto
    Rocha, Paulo Novis
    [J]. BMC NEPHROLOGY, 2017, 18
  • [5] Prevalence and risk factors for Human T-Lymphotropic Virus Type 1 (HTLV-1) among maintenance hemodialysis patients
    Rilma F. S. Santos
    Gildásio C. Conceição
    Márcia S. Martins
    Angiolina Kraychete
    Maria A. C. Penalva
    Edgar M. Carvalho
    Antonio Alberto Lopes
    Paulo Novis Rocha
    [J]. BMC Nephrology, 18
  • [6] Human T-Lymphotropic Virus Type 1 (HTLV-1): Persistence and Immune Control
    Charles R. M. Bangham
    [J]. International Journal of Hematology, 2003, 78 : 297 - 303
  • [7] Human T-lymphotropic virus type 1 (HTLV-1): Persistence and immune control
    Bangham, CRM
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2003, 78 (04) : 297 - 303
  • [8] Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki
    Chiyoda, S
    Kinoshita, K
    Egawa, S
    Inoue, J
    Watanabe, K
    Ifuku, M
    [J]. INTERNAL MEDICINE, 2001, 40 (01) : 14 - 17
  • [9] The prevalence of human T-lymphotropic virus type 1 & 2 (HTLV-1/2) in South African blood donors
    Vermeulen, Marion
    Sykes, Wendy
    Coleman, Charl
    Custer, Brian
    Jacobs, Genevieve
    Jaza, Jabulisile
    Kaidarova, Zhanna
    Hlela, Carol
    Gessain, Antoine
    Cassar, Olivier
    Poole, Colwyn
    Ingram, Charlotte
    Murphy, Edward L.
    Reddy, Ravi
    [J]. VOX SANGUINIS, 2019, 114 (05) : 451 - 458
  • [10] Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation
    Lairmore, MD
    Silverman, L
    Ratner, L
    [J]. ONCOGENE, 2005, 24 (39) : 6005 - 6015